AAUM (Average Assets Under Management) of ₹1,949.97 Cr for Jul-Sep 2026 is the combined figure across Direct and Regular plans — sourced from AMFI India's quarterly disclosure. Equity Holdings above shows only the stock portion from the latest portfolio filing.
| Sector | Prev | Curr ▼ | Delta |
|---|---|---|---|
| Banks | 26.9% | 27.7% | ▲ +0.7% |
| Automobiles | 5.7% | 5.7% | ● 0.0% |
| IT - Software | 6.6% | 5.5% | ▼ -1.1% |
| Industrial Products | 5.1% | 4.7% | ▼ -0.4% |
| Construction | 4.2% | 4.6% | ▲ +0.4% |
| Pharmaceuticals & Biotechnology | 4.8% | 3.8% | ▼ -1.0% |
| Telecom - Services | 4.1% | 3.7% | ▼ -0.4% |
| Petroleum Products | 3.5% | 3.5% | ● -0.1% |
| Cement & Cement Products | 4.7% | 3.4% | ▼ -1.3% |
| Retailing | 3.0% | 3.3% | ▲ +0.3% |
| Sector | Prev | Curr ▼ | Delta |
|---|---|---|---|
| Banks | 27.7% | 27.7% | ● +0.1% |
| Automobiles | 5.7% | 5.7% | ● +0.0% |
| Industrial Products | 4.7% | 5.2% | ▲ +0.6% |
| IT - Software | 5.5% | 5.0% | ▼ -0.5% |
| Construction | 4.6% | 4.6% | ● +0.0% |
| Telecom - Services | 3.7% | 3.8% | ▲ +0.1% |
| Retailing | 3.3% | 3.5% | ▲ +0.2% |
| Cement & Cement Products | 3.4% | 3.4% | ● +0.1% |
| Petroleum Products | 3.5% | 3.4% | ● 0.0% |
| Pharmaceuticals & Biotechnology | 3.8% | 3.2% | ▼ -0.6% |
Comparing Aug 2026 → Sep 2026
| # | Stock | Sector | Last Weight (Aug 2026) |
|---|---|---|---|
| 1 | Cipla Limited ₹14.80 Cr |
Pharmaceuticals & Biotechnology | 0.75% |
| # | Stock | Sector | Aug 2026 | Sep 2026 | Change |
|---|---|---|---|---|---|
| 1 | Kirloskar Oil Engines Limited ₹68.76 Cr |
Industrial Products | 3.19% | 3.74% | +0.55% |
| 2 | HDFC Bank Limited ₹108.08 Cr |
Banks | 5.51% | 5.88% | +0.37% |
| 3 | Elecon Engineering Company Limited ₹26.46 Cr |
Electrical Equipment | 1.20% | 1.44% | +0.24% |
| 4 | Tata Steel Limited ₹22.80 Cr |
Ferrous Metals | 1.01% | 1.24% | +0.23% |
| 5 | Kotak Mahindra Bank Limited ₹62.55 Cr |
Banks | 3.21% | 3.40% | +0.19% |
| 6 | Whirlpool of India Limited ₹20.74 Cr |
Consumer Durables | 0.95% | 1.13% | +0.18% |
| 7 | Bharti Airtel Limited ₹69.58 Cr |
Telecom - Services | 3.66% | 3.79% | +0.13% |
| 8 | ITC Limited ₹25.09 Cr |
Diversified FMCG | 1.24% | 1.37% | +0.13% |
| 9 | The Phoenix Mills Limited ₹25.64 Cr |
Realty | 1.28% | 1.40% | +0.12% |
| 10 | Zydus Lifesciences Limited ₹31.37 Cr |
Pharmaceuticals & Biotechnology | 1.60% | 1.71% | +0.11% |
| # | Stock | Sector | Aug 2026 | Sep 2026 | Change |
|---|---|---|---|---|---|
| 1 | Infosys Limited ₹52.73 Cr |
IT - Software | 3.36% | 2.87% | -0.49% |
| 2 | ICICI Bank Limited ₹118.62 Cr |
Banks | 6.65% | 6.46% | -0.19% |
| 3 | State Bank of India ₹65.92 Cr |
Banks | 3.71% | 3.59% | -0.12% |
| 4 | IndusInd Bank Limited ₹34.03 Cr |
Banks | 1.96% | 1.85% | -0.11% |
| 5 | Mahindra & Mahindra Limited ₹41.29 Cr |
Automobiles | 2.34% | 2.25% | -0.09% |
| 6 | IDFC First Bank Limited ₹17.63 Cr |
Banks | 1.05% | 0.96% | -0.09% |
| 7 | Mahindra & Mahindra Financial Services Limited ₹20.43 Cr |
Finance | 1.20% | 1.11% | -0.09% |
| 8 | 360 One WAM Limited ₹22.73 Cr |
Capital Markets | 1.32% | 1.24% | -0.08% |
| 9 | Amara Raja Energy & Mobility Ltd ₹12.90 Cr |
Auto Components | 0.78% | 0.70% | -0.08% |
| 10 | Tata Motors Ltd ₹28.55 Cr |
Agricultural, Commercial & Construction Vehicles | 1.63% | 1.55% | -0.08% |
53 stocks — Sep 2026
| # | Stock | Sector | Cap | Weight & Value |
|---|---|---|---|---|
| 1 |
₹118.62 Cr |
Banks |
6.46%
|
|
| 2 |
₹108.08 Cr |
Banks |
5.88%
|
|
| 3 |
₹81.53 Cr |
Banks |
4.44%
|
|
| 4 |
₹69.58 Cr |
Telecom - Services |
3.79%
|
|
| 5 |
₹68.76 Cr |
Industrial Products |
3.74%
|
|
| 6 |
₹65.92 Cr |
Banks |
3.59%
|
|
| 7 |
₹64.78 Cr |
Construction |
3.53%
|
|
| 8 |
₹62.91 Cr |
Petroleum Products |
3.42%
|
|
| 9 |
₹62.55 Cr |
Banks |
3.40%
|
|
| 10 |
₹52.73 Cr |
IT - Software |
2.87%
|
Disclaimer: Data sourced from individual AMC monthly portfolio disclosures, as mandated by SEBI/AMFI. While we strive for accuracy, errors in parsing or presentation may occasionally occur. This is not investment advice. Please consult a SEBI-registered investment adviser before making any investment decisions.
Found a discrepancy or have feedback? Contact Us — we read every message personally.